-
BEAT COVID Viral Ct
BEAT COVID Viral Ct Research laboratory data of LUMC BEAT COVID cohort. Prospective observational WMO study including 191 COVID-19 patients from April 2020 to March 2021. Over... -
BEAT COVID Info LUMC
BEAT COVID Info LUMC Research laboratory data of LUMC BEAT COVID cohort. Prospective observational WMO study including 191 COVID-19 patients from April 2020 to March 2021. Over... -
test
tasdasd -
Substudy UCC-SMART Oracle
SMART-ORACLE aims to determine the additional value of contrast-enhanced CT of the coronary and carotid arteries on top of traditional cardiovascular risk factors in patients... -
UCC-SMART
The UCC-SMART Study is a single-centre prospective cohort study, ongoing in both inclusion (600 new patients included per year) and follow-up, in which patient care and... -
Substudy UCC-SMART 2
Patients with a history of CVD or diabetes are invited to participate in the SMART-2 substudy. In this study, the baseline measurements of UCC-SMART are repeated in order to... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
Questionnaire data of the Personalised RISk-based MAmmascreening Study (PRISMA)
The primary aim of the PRISMA study was to investigate the potential value of risk-tailored versus traditional breast cancer screening protocols in the Netherlands. Data... -
test dataset aux classes
Test dataset for aux classes -
testtest
another test -
test dataset aux classes
Test dataset for aux classes -
HealthDCAT-AP test dataset
This dataset is an example of using HealthDCAT-AP in CKAN